Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab
Clinical trial NCT02628574 · COMPLETED
Trial details
- NCT number
- NCT02628574
- Sponsor
- Leap Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2020-07-14
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.